More than 1 million patients undergo cardiac surgery every year in the United States and Europe alone.
1 One of its most common complications is acute kidney injury (AKI), which is associated with morbidity and mortality.
2 Moreover, AKI requiring renal replacement therapy (RRT) (dialysis) affects approximately 5% of patients admitted to the intensive care unit (ICU), is associated with a mortality rate of up to 60%,
3 and markedly increases the cost of care.